MSD CEO BenShoshan, “I have high expectations on the Korean market”

Published: 2016-05-23 12:49:44

Updated: 2016-05-23 12:49:44

“The Korean branch is one of the top 10 major branches selected by the MSD’s headquarters. We will put our best effort to much promptly receive the supply of new drugs than other markets.“

On the 19^th, Avi BenShoshan, a new CEO of MSD Korea, showed a high expectation on the Korean pharmaceutical market at the MSD’s 125^th Anniversary Press Conference.

Followed by CEO Dong-wook Hyun who will be...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.